Assertio Holdings (ASRT) Cash & Current Investments (2019 - 2026)

Assertio Holdings' (ASRT) quarterly Cash & Current Investments came in at $71.6 million in Q1 2026, down 18.04% year-on-year from $87.3 million in Q1 2025, and up 12.88% quarter-over-quarter from $63.4 million in Q4 2025.

Assertio Holdings (ASRT) Cash & Current Investments (2019 - 2026) Analysis & Trends

Assertio Holdings has disclosed Cash & Current Investments across 8 years of filings, most recently posting $71.6 million for Q1 2026.

  • Cash & Current Investments for Q1 2026 came in at $71.6 million, down 18.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $71.6 million (down 18.04% YoY), and the FY2025 annual result was $63.4 million, down 36.63% from the prior year.
  • Cash & Current Investments came in at $71.6 million for Q1 2026 at Assertio Holdings, up from $63.4 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $100.1 million in Q4 2024 to a low of $52.3 million in Q2 2022.
  • The 5-year median for Cash & Current Investments is $73.4 million (2023), against an average of $76.7 million.
  • Across the five-year window, Cash & Current Investments jumped 76.42% in 2022 and tumbled 36.63% in 2025, its largest moves.
  • Assertio Holdings' Cash & Current Investments stood at $64.9 million in 2022, then gained by 13.09% to $73.4 million in 2023, then soared by 36.24% to $100.1 million in 2024, then sank by 36.63% to $63.4 million in 2025, then advanced by 12.88% to $71.6 million in 2026.
  • The last three Cash & Current Investments figures came in at $71.6 million (Q1 2026), $63.4 million (Q4 2025), and $93.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 3.74 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 1.94 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 2.15 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 77.77 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.32 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 428.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 511.86 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 750.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 498.58 Mn
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn 71.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 71.57 Mn
Dec 31, 2025 63.41 Mn
Sep 30, 2025 93.43 Mn
Jun 30, 2025 98.18 Mn
Mar 31, 2025 87.33 Mn
Dec 31, 2024 100.05 Mn
Sep 30, 2024 88.58 Mn
Jun 30, 2024 88.38 Mn
Mar 31, 2024 80.74 Mn
Dec 31, 2023 73.44 Mn
Sep 30, 2023 76.89 Mn
Jun 30, 2023 70.18 Mn
Mar 31, 2023 68.60 Mn
Dec 31, 2022 64.94 Mn
Sep 30, 2022 64.83 Mn
Jun 30, 2022 52.26 Mn
Mar 31, 2022 61.39 Mn
Dec 31, 2021 36.81 Mn
Sep 30, 2021 58.73 Mn
Jun 30, 2021 54.43 Mn